State Ledger
Company profile

AbbVie Inc. CIK 1551152

Ticker
ABBV (NYSE)
Industry
Pharmaceutical Preparations
Headquarters
North Chicago, IL 60064
Fiscal year end
2025 (FY)
Market Data
Close
$276.40
Change
+$3.95
Change %
1.45%
Volume
139,113

ABBV · trading date Oct 9, 2026 · previous close $272.46 · source: Alpaca (IEX feed, not consolidated full-market data).

Key Financials
Revenue
$61.16B
Net income
$4.23B
Total assets
$133.96B
Total liabilities
—
Stockholders' equity
-$3.27B
Cash & equivalents
$5.23B
Operating income
$15.08B
Operating cash flow
$19.03B
Capital expenditures
$1.21B

Fiscal year 2025, via 10-K filed 2026-02-20. A dash means this figure wasn't reported in the source filing under a field State Ledger recognizes - not that the value is zero.

Financial Performance
Operating margin
24.6%
Net margin
6.9%
Free cash flow
$17.82B
Free cash flow margin
29.1%
Liabilities / assets
—
Equity / assets
-2.4%
CapEx / revenue
2.0%
Operating cash flow / net income
4.50×

Derived from the fiscal year 2025 figures above. These metrics are mathematical calculations and do not represent a rating or assessment of the company.

Financial History
Fiscal yearRevenueNet incomeAssetsLiabilitiesEquity
2025 $61.16B $4.23B $133.96B — -$3.27B
2024 $56.33B $4.28B $135.16B — $3.33B
2023 $54.32B $4.86B $134.71B — $10.36B
2022 $58.05B $11.84B $138.81B — $17.25B
2021 $56.20B $11.54B $146.53B — $15.41B
Company Details
SIC code
2834
State of incorporation
DE
Active filer
Yes
Most recent SEC filing
Form 8-K
2026-09-03
Financials filed via
Form 10-K
filed 2026-02-20

"Most recent SEC filing" may differ from the filing used for the financial figures above.

Location
North Chicago, IL 60064
1 NORTH WAUKEGAN ROAD
Data & Methodology

SEC EDGAR submissions API (identity, collected Sep 19, 2026, 15:11 UTC) and SEC XBRL Company Facts API (financials, collected Sep 26, 2026, 15:30 UTC) · figures as originally filed, not restated · a dash always means a value wasn't reported, never a real zero.

← Back to Illinois — Public Companies